MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30
April 16, 2024 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., April 16, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the first...
MIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDA
March 27, 2024 08:00 ET
|
MiMedx Group, Inc
Receives Determination Letter from FDA Stating AXIOFILL Does Not Qualify for Classification as an HCT/P Under Section 361 MIMEDX Continues to Pursue All Available Options to Keep AXIOFILL on the...
MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing
March 20, 2024 07:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., March 20, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it has entered into an agreement with TELA Bio, Inc. to obtain...
MIMEDX Introduces E-Commerce and Account Management Platform
March 13, 2024 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., March 13, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the launch of MIMEDX Connect™, an online product ordering and account...
MIMEDX Announces Appointment of Two New Independent Directors
March 04, 2024 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., March 04, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the appointments of Tiffany Olson and Dorothy Puhy to its Board of...
MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results
February 28, 2024 16:01 ET
|
MiMedx Group, Inc
Net Sales Grew 17% Year-Over-Year for the Fourth Quarter and 20% for the Full Year Fourth Quarter Net Income was $53 million, Inclusive of a $40 million One-Time Non-Cash Tax Benefit Fourth Quarter...
MIMEDX to Present at TD Cowen 44th Annual Health Care Conference
February 20, 2024 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., Feb. 20, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that senior management will participate in the TD Cowen 44th Annual...
MIMEDX to Host Fourth Quarter and Full Year 2023 Operating and Financial Results Conference Call on February 28
February 12, 2024 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., Feb. 12, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the fourth...
MIMEDX Announces Improved Capital Structure with New Senior Secured Credit Facilities and Debt Refinancing
January 22, 2024 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., Jan. 22, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it has enhanced its capital structure by refinancing its existing...
MIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin Outlook
December 29, 2023 17:00 ET
|
MiMedx Group, Inc
Receipt of FDA Warning Letter for AXIOFILL Classification; Not Related to Safety Request for Designation for AXIOFILL Submitted to FDA and Currently Under Review Reiterates Expectations for...